MedTrace Logo

Investigating HD-tDCS in Improving Word Finding and Memory Retrieval in Individuals With MCI

NCT03446508 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-02-08

No results posted yet for this study

Summary

This study is attempting to improve word finding and memory retrieval problems persons with mild cognitive impairment (MCI) may have.

Conditions

Interventions

DEVICE

Active frontal

1\) active HD-tDCS will be administered

DEVICE

Active parietal

2\) active HD-tDCS will be administered

DEVICE

Sham

3\) sham HD-tDCS - no current

Sponsors & Collaborators

  • The University of Texas at Dallas

    lead OTHER

Principal Investigators

  • Sven Vanneste, PhD · The University of Texas at Dallas

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-18
Primary Completion
2022-01-25
Completion
2022-01-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03446508 on ClinicalTrials.gov